The destruction of acinar structure occurs in patientswith xerostomia caused by various disorders, including Sjögren's syndrome (SS) and aging. Althoughthe precise mechanism involved in this phenomenonremains unknown, accumulated evidence indicates thatcytokines such as TNF-α and IL-1β play an importantrole in the destruction of acinar structure. Thisarticle summarizes our findings obtained by theanalysis of
in vitro human salivary gland acinar cellclones, and postulates a possible novel therapy for thepreservation and restoration of acinar structure inpatients with xerostomia. The immortalized humansalivary gland cell clone with acinar phenotype (NSSV-AC) was used. NS-SV-AC produced a large amountof MMP-9 in response to TNF-α, and entered apoptosiswhen cells were cultured on type IV collagen-coateddishes in the presence of TNF-α. However, suppressionof MMP-9 production by the transfection of asuper-repressor form of IκB-α cDNA into NS-SV-AC, via the inhibition of TNF-α-induced NF-κB activity, resulted in the prevention of the destruction ofnormal
in vitro morphogenesis. In addition, TNF-α-induce MMP-9 production was effectively suppressedby Cepharanthine through the down-regulation of NF-κB activity. and inhibition of TNF-α-induced MMP-9production restored the aberrant
in vitro morphogenesisof NS-SV-AC. Thus, suppression of TNF-α-induced MMP-9 may be a promising strategy for theclinical therapy of patients with xerostomia.
View full abstract